Trava's products include vitamin B12 (cyanocobalamin) at low supplemental doses
Orforglipron, an investigational daily GLP-1 receptor agonist from Eli Lilly, has reported promising Phase 3 clinical trial results, positioning it as a potential competitor to newly approved oral options like the Wegovy pill (oral semaglutide)
Br J Psychiatry 188:449452 Ohgi Y, Futamura T, Kikuchi T, Hashimoto K (2013) Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration
A prior study had shown that retatrutide and semaglutide reduced pancreatic tumor mass in mice, along with weight loss
Mitochondria may be active, but without enough antioxidant support to balance everyday oxidative exposure
article is a helpful next read